Cite
HARVARD Citation
Richard, K. et al. (n.d.). P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias. Journal for immunotherapy of cancer. p. . [Online].